GE HealthCare Technologies Comprehensive Income 2020-2024 | GEHC
GE HealthCare Technologies comprehensive income from 2020 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
- GE HealthCare Technologies comprehensive income for the quarter ending June 30, 2024 was $-0.845B, a 1307.14% decline year-over-year.
- GE HealthCare Technologies comprehensive income for 2023 was $-0.691B, a 63.21% decline from 2022.
- GE HealthCare Technologies comprehensive income for 2022 was $-1.878B, a 81.1% increase from 2021.
- GE HealthCare Technologies comprehensive income for 2021 was $-1.037B, a 23.6% increase from 2020.
| GE HealthCare Technologies Annual Comprehensive Income (Millions of US $) |
|
|---|---|
| 2023 | $-691 |
| 2022 | $-1,878 |
| 2021 | $-1,037 |
| 2020 | $-839 |
| 2019 | $ |
| GE HealthCare Technologies Quarterly Comprehensive Income (Millions of US $) |
|
|---|---|
| 2024-06-30 | $-845 |
| 2024-03-31 | $-787 |
| 2023-12-31 | $-691 |
| 2023-09-30 | $-280 |
| 2023-06-30 | $70 |
| 2023-03-31 | $75 |
| 2022-12-31 | $-1,878 |
| 2022-09-30 | $-1,942 |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2020-12-31 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $40.428B | $19.552B |
| Chicago, IL-based GE Healthcare is a leading maker of medical imaging and patient-monitoring products and related equipment and services. Approximately half of GE Healthcare's revenue comes from equipment sales, with consumables and services accounting for the other half. GE Healthcare started operating as an independent company after its January 2023 spin-off from General Electric (GE). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $7.918B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $6.215B | 1157.72 |
| Axonics (AXNX) | United States | $3.513B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $3.503B | 203.88 |
| 10x Genomics (TXG) | United States | $2.660B | 0.00 |
| Enovis (ENOV) | United States | $2.437B | 17.67 |
| Azenta (AZTA) | United States | $2.413B | 137.03 |
| Privia Health (PRVA) | United States | $2.280B | 158.92 |
| IRhythm Technologies (IRTC) | United States | $2.219B | 0.00 |
| Omnicell (OMCL) | United States | $1.968B | 64.82 |
| Clover Health Investments (CLOV) | United States | $1.492B | 0.00 |
| Schrodinger (SDGR) | United States | $1.436B | 0.00 |
| Phreesia (PHR) | United States | $1.389B | 0.00 |
| Standard BioTools (LAB) | United States | $0.753B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.694B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.538B | 456.00 |
| Health Catalyst (HCAT) | United States | $0.529B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.406B | 0.00 |
| Talkspace (TALK) | United States | $0.343B | 0.00 |
| Pulmonx (LUNG) | United States | $0.329B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.286B | 0.00 |
| TruBridge (TBRG) | United States | $0.183B | 13.44 |
| P3 Health Partners (PIII) | United States | $0.165B | 0.00 |
| American Well (AMWL) | United States | $0.147B | 0.00 |
| Augmedix (AUGX) | United States | $0.115B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.090B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.055B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| 111 (YI) | China | $0.051B | 0.00 |
| Zepp Health (ZEPP) | China | $0.049B | 0.00 |
| CareCloud (CCLD) | United States | $0.045B | 0.00 |
| Movano (MOVE) | United States | $0.036B | 0.00 |
| Outset Medical (OM) | United States | $0.034B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.025B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.024B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.018B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Syra Health (SYRA) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |